117
Participants
Start Date
March 31, 2011
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
Estriol 0.1% vaginal cream
Patients with both vulvovaginal atrophy (according to cytologic criteria) and dyspareunia will apply 0.5 ml of the cream (0.5 mg) to the vulvar vestibule once daily for one month and will return for check-up visit. In case both atrophy and dyspareunia will resolve, treatment with the cream will be continued 3 times a week.
Clalit Women's Health Center, Jerusalem
Clalit Women's Health Center, Modiin
Lead Sponsor
Meir Medical Center
OTHER